Christopher R. Christensen Pennant Group, Inc. (PNTG) insider trading activity

Christopher R. Christensen is Director of Pennant Group, Inc.. Currently has a direct ownership of 140,291 shares of PNTG, which is worth approximately $3.52 Million. The most recent transaction as insider was on Oct 15, 2025, when has been sold 1,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 140K

1.37% 3M change

5.73% 12M change

Total Value Held $3.52 Million

Christopher R. Christensen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 15 2025	BUY Grant, award, or other acquisition	-	1,900 Added 1.34%	140,291 Common Stock
Jul 15 2025	BUY Grant, award, or other acquisition	-	1,900 Added 1.35%	138,391 Common Stock
Apr 15 2025	BUY Grant, award, or other acquisition	-	1,900 Added 1.37%	136,491 Common Stock
Jan 15 2025	BUY Grant, award, or other acquisition	-	1,900 Added 1.39%	134,591 Common Stock
Oct 15 2024	BUY Grant, award, or other acquisition	-	3,000 Added 2.21%	132,691 Common Stock
Sep 10 2024	SELL Bona fide gift	-	11,927 Reduced 8.42%	129,691 Common Stock
Jul 15 2024	BUY Grant, award, or other acquisition	$78,750 $26.25 p/Share	3,000 Added 2.07%	141,618 Common Stock
Apr 15 2024	BUY Grant, award, or other acquisition	-	3,000 Added 2.12%	138,618 Common Stock
Jan 16 2024	BUY Grant, award, or other acquisition	-	3,000 Added 2.16%	135,618 Common Stock
Nov 03 2023	SELL Bona fide gift	-	250 Reduced 0.19%	132,618 Common Stock
Oct 27 2023	SELL Bona fide gift	-	30,037 Reduced 18.44%	132,868 Common Stock
Oct 16 2023	BUY Grant, award, or other acquisition	-	1,500 Added 0.91%	162,905 Common Stock
Jul 17 2023	BUY Grant, award, or other acquisition	-	1,500 Added 0.92%	161,405 Common Stock
Apr 18 2023	BUY Grant, award, or other acquisition	-	1,500 Added 0.93%	159,905 Common Stock
Jan 17 2023	BUY Grant, award, or other acquisition	-	4,500 Added 2.76%	158,405 Common Stock
Oct 17 2022	BUY Grant, award, or other acquisition	-	750 Added 0.48%	153,905 Common Stock
Jul 15 2022	BUY Grant, award, or other acquisition	-	750 Added 0.49%	153,155 Common Stock
Jun 10 2022	SELL Open market or private sale	$45,652 $16.2 p/Share	2,818 Reduced 1.82%	152,405 Common Stock
Apr 18 2022	BUY Grant, award, or other acquisition	-	750 Added 0.48%	155,223 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	-	750 Added 0.48%	154,473 Common Stock
Oct 15 2021	BUY Grant, award, or other acquisition	-	750 Added 0.49%	153,723 Common Stock
Aug 31 2021	SELL Payment of exercise price or tax liability	$3,051 $30.51 p/Share	100 Reduced 0.07%	152,973 Common Stock
Jul 15 2021	BUY Grant, award, or other acquisition	-	750 Added 0.49%	153,073 Common Stock
Apr 15 2021	BUY Grant, award, or other acquisition	-	750 Added 0.49%	152,323 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	$43,155 $57.54 p/Share	750 Added 0.49%	151,573 Common Stock

Also insider at

ENSG

ENSIGN GROUP, INC Healthcare

Executive Chairman

CRC